FlexDex intuitive laparoscopic accompaniments to begin sale in the US

Introduction of FlexDex intuitive technology has revolutionized the way minimal invasive surgeries are performed by lending the ease of movements and intuitive control than traditional laparoscopic instruments.

Using the ‘virtual center,’ the platform precisely translates the movement of surgeon’s wrist, hand, and arm outside the patient’s body into the corresponding movements of the instrument tip inside the patient body. Unlike any other instrument, it allows the surgeons to move the wrist in the direction of intended movement thereby greatly simplifying the execution of the surgical procedure.

Until now, FlexDex only provided the technology to a few hospitals as part of clinical trials. Now, FlexDex has entered into exclusive distribution agreement with Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures to distribute FlexDex’s Needle Driver instrument in the United States.

The agreement combines Olympus’ innovative 3D laparoscopic imaging technology and FlexDex’s wristed needle-driver to offer a low-cost, robust alternative for complicated high-cost robotic set-up.

Randy Clark, Group Vice President of the Surgical Division at Olympus said in a news release, “Combining Olympus’ expertise in minimally invasive surgery and 3D technology with FlexDex’s unique technology for handling surgical instruments -- without the complexity and cost of a computer-aided robotic system -- will be a game changer for physicians and patients. We are thrilled to add FlexDex to the Olympus portfolio, furthering our progress of improving patient satisfaction, decreasing costs and improving the quality of life for patients.”

“Hospitals are constantly under pressure to reduce cost and improve patient outcomes. Using a multi-million-dollar robotic system for procedures that have low margins, often associated with fixed reimbursement, can potentially further burden providers financially. FlexDex and Olympus are uniquely positioned to offer surgeons the precision and control they desire while maintaining the balance of cost, outcome and patient benefit,” added Dr. James Geiger, CEO at FlexDex.

Flashback: FlexDex, a revolutionary laparoscopic technology that moves like surgeon’s hand

Product page

Olympus newsrelease

Ob/Gyn Updated Facebook page

News from ACOG 2017: Olympus unveils its new plasma hystero-resectoscope at the conference.

Olympus (Center Valley, Pennsylvania) a  global leader in designing innovative solutions for  medical and surgical procedure  recently announced its launch of new plasma hystero-resectoscope and other products of the entire  portfolio. 

The plasma hysteroscopic system was showcased at the American Congress of Obstetricians and Gynecological Annual Meeting (ACOG) May 6-9 in San Diego, CA.

These range of products have received FDA clearance based on lower risk of hyponatremia during the surgery as compared to monopolar electrosurgery. The lower risk of electrolyte imbalance along with precision in cutting, and better visibility improves patient outcome. It is also   cost-effective for a wide range of hysteroscopic procedures.

Plasma is one of the four fundamental states of matter besides solid, liquid, and gas. When a gas is ionized by passing current through it, electrons are stripped from its atoms, turning it into plasma.

The plasma energy is generated as a precise stream that dissipates rapidly as it comes in contact with the tissue, but with controlled penetration and minimal thermal effect.

The Olympus 8.5 mm hystero-resectoscope, in use with the world’s first 4 MM high definition telescope is used in many gynecological procedures because of its array of different type of plasma electrodes.

• The vaporization electrodes are very efficient and save lot of surgical time because it eliminates the need of for multiple resectoscope reinsertions.
• Variety of loop sizes for allows for quicker resection and coagulation of polyps, myomas and the endometrium.
• It also has a needle electrode for septum resection.

"The Olympus plasma hysteroscopic resection and vaporization system advances operative hysteroscopy to a new level of capability," said Dr. Benjamin Gocial at Main Line Fertility. 

"Olympus builds upon its excellent track record with plasma resection and vaporization through these 510(k) clearances, and we expect enthusiastic adoption of the technology in gynecology," said Randy Clark, Group Vice President of the Surgical Division at Olympus America Inc. "We have aimed not only to bring improved patient outcomes to our customers, but to provide an advanced gynecology portfolio that is cost effective for Hospitals and Ambulatory Surgery Centers."